ALPROLIX
ALPROLIX
Approved
DIN Number
02422905
Drug Class
Human
Market Date
N/A
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02422905
AIG Number0155510001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD04 COAGULATION FACTOR IX
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEINActive
Strength: 250 UNIT / VIAL
Monograph: RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN